Literature DB >> 2019059

Autologous marrow injection as a substitute for operative grafting of tibial nonunions.

J F Connolly1, R Guse, J Tiedeman, R Dehne.   

Abstract

Autologous marrow injection was used to stimulate healing in 20 ununited tibial fractures over a five-year period. The technique was employed in conjunction with cast immobilization in ten cases and intramedullary nail fixation in ten cases. Marrow stimulated a callus formation sufficient to unite eight of the ten nonunions immobilized with casts and all ten of the fractures immobilized by intramedullary nails. Bone-marrow injection was as effective as past open autologous grafting but with considerably fewer disadvantages. The technique provides a promptly renewable and reliable source of osteogenic stem cells with numerous advantages compared with standard open-grafting techniques.

Entities:  

Mesh:

Year:  1991        PMID: 2019059

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  67 in total

1.  Spine fusion using cell matrix composites enriched in bone marrow-derived cells.

Authors:  George F Muschler; Hironori Nitto; Yoichi Matsukura; Cynthia Boehm; Antonio Valdevit; Helen Kambic; William Davros; Kimerly Powell; Kirk Easley
Journal:  Clin Orthop Relat Res       Date:  2003-02       Impact factor: 4.176

2.  Bone healing: little secrets.

Authors:  Thomas A Einhorn
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

Review 3.  Recent biological trends in management of fracture non-union.

Authors:  Khaled M Emara; Ramy Ahmed Diab; Ahmed Khaled Emara
Journal:  World J Orthop       Date:  2015-09-18

4.  Selective retention of bone marrow-derived cells to enhance spinal fusion.

Authors:  George F Muschler; Yoichi Matsukura; Hironori Nitto; Cynthia A Boehm; Antonio D Valdevit; Helen E Kambic; William J Davros; Kirk A Easley; Kimerly A Powell
Journal:  Clin Orthop Relat Res       Date:  2005-03       Impact factor: 4.176

5.  Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2.

Authors:  A M Ozturk; E Cila; U Kanatli; I Isik; A Senkoylu; D Uzunok; E Piskin
Journal:  Int Orthop       Date:  2005-02-10       Impact factor: 3.075

6.  2011 AOA Symposium: Tissue Engineering and Tissue Regeneration: AOA critical issues.

Authors:  Scott A Rodeo; Scott D Boden; Martha M Murray; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2013-08-07       Impact factor: 5.284

7.  A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP.

Authors:  Xueqin Gao; Arvydas Usas; Ying Tang; Aiping Lu; Jian Tan; Johannes Schneppendahl; Adam M Kozemchak; Bing Wang; James H Cummins; Rocky S Tuan; Johnny Huard
Journal:  Biomaterials       Date:  2014-05-21       Impact factor: 12.479

8.  Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2-Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow.

Authors:  Sofia Bougioukli; Osamu Sugiyama; William Pannell; Brandon Ortega; Matthew H Tan; Amy H Tang; Robert Yoho; Daniel A Oakes; Jay R Lieberman
Journal:  Hum Gene Ther       Date:  2018-03-14       Impact factor: 5.695

9.  Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP.

Authors:  Dezhong Yin; Zhuo Wang; Qinghong Gao; Renuka Sundaresan; Chris Parrish; Qingfen Yang; Paul H Krebsbach; Alexander C Lichtler; David W Rowe; Janet Hock; Peng Liu
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

10.  BMP2 is superior to BMP4 for promoting human muscle-derived stem cell-mediated bone regeneration in a critical-sized calvarial defect model.

Authors:  Xueqin Gao; Arvydas Usas; Aiping Lu; Ying Tang; Bing Wang; Chien-Wen Chen; Hongshuai Li; Jessica C Tebbets; James H Cummins; Johnny Huard
Journal:  Cell Transplant       Date:  2012-11-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.